Copyright
©The Author(s) 2020.
World J Clin Cases. Nov 6, 2020; 8(21): 5172-5179
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5172
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5172
Table 3 Comparison of quality-of-life scores between the two groups
| GQOLI-74 score (point) | S-1 group (n = 47) | Gemcitabine group (n = 47) | t | P value |
| Material | 60.53 (4.31) | 59.97 (4.06) | 0.648 | 0.518 |
| Society | 63.84 (3.54) | 62.59 (3.61) | 1.695 | 0.094 |
| Psychology | 67.14 (3.68) | 66.42 (3.56) | 0.964 | 0.338 |
| Body | 63.12 (3.97) | 62.47 (3.78) | 0.813 | 0.418 |
- Citation: Cheng XW, Leng WH, Mu CL. Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients. World J Clin Cases 2020; 8(21): 5172-5179
- URL: https://www.wjgnet.com/2307-8960/full/v8/i21/5172.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i21.5172